RecruitingNot ApplicableNCT06493175

The Application of Large Language Model in Emergency Chest Pain Triage


Sponsor

Peking University Third Hospital

Enrollment

2,000 participants

Start Date

Dec 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate the accuracy and efficiency of large language model in emergency triage.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • All patients with chest pain entered the emergency triage procedure.
  • patients aged 18 and above.

Exclusion Criteria7

  • Patients with severe cognitive impairment or inability to communicate.
  • There are patients who have been explicitly referred to specific departments (for example, some of the 120 transfer patients, who may go directly to the green channel) .
  • Patients with unstable vital signs .
  • Patients with potential medical problems.
  • Is participating in other clinical trials.
  • Failure to follow test procedures.
  • Those who refuse to sign the informed consent form.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTApplication of large language model in emergency chest pain triage.

The large language model MedGuide-V5 is able to quickly extract key information from a patients description, and by analyzing these descriptions, it provides physicians with a possible initial diagnosis to help them quickly prioritize the treatment of patients.

DIAGNOSTIC_TESTAccording to the normal procedures to receive medical treatment

After the artificial intelligence system evaluation, the patients will receive the diagnosis and treatment according to the normal procedure. The overall time of artificial triage, the triage of patients, and other data will be recorded. Patient visits should not be delayed by the use of artificial intelligence systems for evaluation.


Locations(1)

Peking University Third Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06493175


Related Trials